Should prasugrel or clopidogrel be used in patients with ACS?

被引：0
|
作者：
Neal S. Kleiman
机构：
来源：
Current Cardiology Reports | 2008年 / 10卷 / 4期
关键词：
Acute Coronary Syndrome; Clopidogrel; Stent Thrombosis; Ticlopidine; Prasugrel;
D O I：
10.1007/s11886-008-0048-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：301 / 302
页数：1
相关论文
共 50 条
  • [21] Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience
    Giuseppe De Luca
    Monica Verdoia
    Alon Schaffer
    Harry Suryapranata
    Guido Parodi
    David Antoniucci
    Paolo Marino
    Journal of Thrombosis and Thrombolysis, 2014, 38 : 388 - 394
  • [22] Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study
    Chandrasekhar, Jaya
    Baber, Usman
    Sartori, Samantha
    Aquino, Melissa
    Henry, Timothy D.
    Kini, Annapoorna
    Kapadia, Samir
    Rao, Sunil
    Weiss, Sandra
    Muhlestein, Joseph B.
    Poddar, Kanhaiya L.
    Baker, Brian A.
    Keller, Stuart Y.
    Effron, Mark B.
    Chao, Jennifer
    Strauss, Craig E.
    DeFranco, Anthony
    Weintraub, William
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B84 - B85
  • [23] A pharmacodynamics comparison of prasugrel and clopidogrel in patients undergoing hemodialysis
    Taro Kamada
    Masamichi Iwasaki
    Akihide Konishi
    Toshiro Shinke
    Hiroshi Okamoto
    Takatoshi Hayashi
    Ken-ichi Hirata
    Heart and Vessels, 2019, 34 : 883 - 887
  • [24] Prasugrel versus clopidogrel in patients with acute coronary syndromes
    Wiviott, Stephen D.
    Braunwald, Eugene
    McCabe, Carolyn H.
    Montalescot, Gilles
    Ruzyllo, Witold
    Gottlieb, Shmuel
    Neumann, Franz-Joseph
    Ardissino, Diego
    De Servi, Stefano
    Murphy, Sabina A.
    Riesmeyer, Jeffrey
    Weerakkody, Govinda
    Gibson, C. Michael
    Antman, Elliott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2001 - 2015
  • [25] A pharmacodynamics comparison of prasugrel and clopidogrel in patients undergoing hemodialysis
    Kamada, Taro
    Iwasaki, Masamichi
    Konishi, Akihide
    Shinke, Toshiro
    Okamoto, Hiroshi
    Hayashi, Takatoshi
    Hirata, Ken-ichi
    HEART AND VESSELS, 2019, 34 (06) : 883 - 887
  • [26] Low prasugrel vs high clopidogrel dose in patients aged greater than or equal to 75 years with ACS and high on clopidogrel platelet reactivity post PCI
    Xanthopoulou, I.
    Plakomyti, T. -E.
    Theodoropoulos, K. F.
    Kassimis, G.
    Mauronasiou, E.
    Moulias, A.
    Damelou, A.
    Davlouros, P.
    Hahalis, G.
    Alexopoulos, D.
    EUROPEAN HEART JOURNAL, 2012, 33 : 317 - 318
  • [27] Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial
    Yan, Andrew T.
    Roe, Matthew T.
    Neely, Megan
    Cyr, Derek D.
    White, Harvey
    Fox, Keith A. A.
    Prabhakaran, Dorairaj
    Armstrong, Paul W.
    Ohman, Erik M.
    Goodman, Shaun G.
    CORONARY ARTERY DISEASE, 2018, 29 (06) : 469 - 476
  • [28] Prasugrel: A Critical Comparison with Clopidogrel
    Reinhart, Kurt M.
    White, C. Michael
    Baker, William L.
    PHARMACOTHERAPY, 2009, 29 (12): : 1441 - 1451
  • [29] Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users
    Olson, William H.
    Ma, Yi-Wen
    Crivera, Concetta
    Schein, Jeff
    Lefebvre, Patrick
    Laliberte, Francois
    Dea, Katherine
    Germain, Guillaume
    Lynch, Scott M.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1074 - 1084
  • [30] A comparison of the metabolism of clopidogrel and prasugrel
    Laizure, S. Casey
    Parker, Robert B.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1417 - 1424
12345